Circulating microRNA expression is associated with genetic subtype and survival of multiple myeloma
暂无分享,去创建一个
R. Zhong | Juan Yu | Jing-jing Huang | Juan Yu | Jiang-yan Li | Yao-ting Liu | Ren-qian Zhong | Jiang Li | Jing-jing Huang | Yaobang Liu
[1] C. Burge,et al. Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.
[2] Hsuan-Cheng Huang,et al. Integrative network analysis reveals active microRNAs and their functions in gastric cancer , 2011, BMC Systems Biology.
[3] Eun Kyung Kim,et al. Aberrant expression of let-7a miRNA in the blood of non-small cell lung cancer patients. , 2011, Molecular medicine reports.
[4] Xin Zhou,et al. Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation. , 2011, Oncology reports.
[5] J. Chi,et al. MicroRNA expression in multiple myeloma is associated with genetic subtype, isotype and survival , 2011, Biology Direct.
[6] Vivek Jayaswal,et al. Expression profiling of cytogenetically normal acute myeloid leukemia identifies MicroRNAs that target genes involved in monocytic differentiation , 2011, American journal of hematology.
[7] Jianyong Li,et al. miR-17-92 cluster microRNAs confers tumorigenicity in multiple myeloma. , 2011, Cancer letters.
[8] H. Tagawa,et al. Synergistic action of the microRNA‐17 polycistron and Myc in aggressive cancer development , 2007, Cancer science.
[9] S. Grimmond,et al. The miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transition , 2008, Genome Biology.
[10] Xianghuo He,et al. MicroRNA-148a Suppresses Tumor Cell Invasion and Metastasis by Downregulating ROCK1 in Gastric Cancer , 2011, Clinical Cancer Research.
[11] J. Cheng,et al. MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma , 2010, Molecular Cancer.
[12] Jia Yu,et al. miRNA-96 suppresses KRAS and functions as a tumor suppressor gene in pancreatic cancer. , 2010, Cancer research.
[13] H. Hashimoto,et al. Identification of altered MicroRNA expression patterns in synovial sarcoma , 2011, Genes, chromosomes & cancer.
[14] T. Godfrey,et al. MicroRNA prognostic signature for nodal metastases and survival in esophageal adenocarcinoma. , 2011, The Annals of thoracic surgery.
[15] M. Babjuk,et al. Importance of miR-20a expression in prostate cancer tissue. , 2010, Anticancer research.
[16] Hongwei Zhang,et al. miRNA-223 Promotes Gastric Cancer Invasion and Metastasis by Targeting Tumor Suppressor EPB41L3 , 2011, Molecular Cancer Research.
[17] R. Porcher,et al. Clinical and biological features of t(4;14) multiple myeloma: a prospective study , 2011, Leukemia & lymphoma.
[18] Michaela Scherr,et al. Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells. , 2007, Blood.
[19] Gabriele Sales,et al. Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma. , 2009, Blood.
[20] Á. Zaballos,et al. Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival , 2010, European Respiratory Journal.
[21] J. M. Thomson,et al. Transgenic over-expression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells. , 2007, Developmental biology.
[22] G. Morgan,et al. Deletion of chromosome 13 detected by conventional cytogenetics is a critical prognostic factor in myeloma , 2006, Leukemia.
[23] David J. Galas,et al. MicroRNA as biomarkers and regulators in B-cell chronic lymphocytic leukemia , 2011, Proceedings of the National Academy of Sciences.
[24] George A Calin,et al. MicroRNAs miR-221 and miR-222: a new level of regulation in aggressive breast cancer , 2011, Genome Medicine.
[25] David R Williams,et al. High-risk myeloma is associated with global elevation of miRNAs and overexpression of EIF2C2/AGO2 , 2010, Proceedings of the National Academy of Sciences.
[26] George A. Calin,et al. MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases , 2009, Expert opinion on biological therapy.
[27] Youliang Wang,et al. miR-148a Promoted Cell Proliferation by Targeting p27 in Gastric Cancer Cells , 2011, International journal of biological sciences.
[28] R. Tibshirani,et al. Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[29] G. Gahrton,et al. Impact of chromosome 13 deletion and plasma cell load on long-term survival of patients with multiple myeloma undergoing autologous transplantation. , 2009, Oncology reports.
[30] Ankit Malhotra,et al. miR-99 family of MicroRNAs suppresses the expression of prostate-specific antigen and prostate cancer cell proliferation. , 2011, Cancer research.
[31] W. Lam,et al. Genome-wide identification of human microRNAs located in leukemia-associated genomic alterations. , 2009, Blood.
[32] Daniel B. Martin,et al. Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.
[33] L. Michaux,et al. The t(14;20)(q32;q12): a rare cytogenetic change in multiple myeloma associated with poor outcome , 2010, British journal of haematology.
[34] H. Rehrauer,et al. Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1. , 2011, Blood.
[35] G. Morgan,et al. Age has a profound effect on the incidence and significance of chromosome abnormalities in myeloma , 2005, Leukemia.
[36] Thomas D. Schmittgen,et al. miR-221 silencing blocks hepatocellular carcinoma and promotes survival. , 2011, Cancer research.
[37] Muller Fabbri,et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. , 2005, The New England journal of medicine.
[38] Yingyan Yu,et al. miRNA-331-3p directly targets E2F1 and induces growth arrest in human gastric cancer. , 2010, Biochemical and biophysical research communications.
[39] G. Ahmann,et al. Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocations , 2006, Leukemia.
[40] Yuefeng Yang,et al. Overexpression of microRNA-29b induces apoptosis of multiple myeloma cells through down regulating Mcl-1. , 2011, Biochemical and biophysical research communications.
[41] Y. Homma,et al. miR-148a is an androgen-responsive microRNA that promotes LNCaP prostate cell growth by repressing its target CAND1 expression , 2010, Prostate Cancer and Prostatic Diseases.
[42] R. Gold,et al. Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system. , 2011, Blood.
[43] C. Croce,et al. MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis , 2008, Proceedings of the National Academy of Sciences.